Medivir’s fostrox + Lenvima confirm promise of improved outcomes in advanced liver cancer, detailed and mature data presented at ESMO
Read moreMedivir to present mature clinical data for fostrox + Lenvima at ESMO Conference and to host a webcast on September 16
Read moreQuarterly report presentations
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.